Financhill
Sell
36

JANX Quote, Financials, Valuation and Earnings

Last price:
$13.10
Seasonality move :
79.05%
Day range:
$13.02 - $13.39
52-week range:
$12.12 - $38.42
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
79.31x
P/B ratio:
0.81x
Volume:
813.6K
Avg. volume:
1.5M
1-year change:
-64.81%
Market cap:
$786.7M
Revenue:
$10.6M
EPS (TTM):
-$1.68

Earnings Data

Next earnings date for JANX
Feb 26
2026
Most recent earnings per share
-$0.39
Beat by $0.22
(Nov 6/2025)
Consensus Estimate
-$0.61
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

JANX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 $944.4K -- -- -$0.71 --
02/26/2026 Q4 $71.4K -- -- -$0.64 --
11/06/2025 Q3 $3.1M $10M -$0.39 -$0.61 $0.22
08/07/2025 Q2 $272.7K -- -$0.55 -$0.47 -$0.08
05/08/2025 Q1 $650K -- -$0.38 -$0.39 $0.01
12/31/2024 Q4 $1.3M -- -$0.36 -$0.45 $0.10
11/06/2024 Q3 $1.6M $439K -$0.51 -$0.36 -$0.16
08/07/2024 Q2 $863.1K $8.9M -$0.11 -$0.29 $0.18
05/08/2024 Q1 $1M $1.3M -$0.30 -$0.33 $0.03
03/08/2024 Q4 $739.3K $2.5M -$0.25 -$0.39 $0.14
11/07/2023 Q3 $845.5K $2.5M -$0.25 -$0.43 $0.18
08/08/2023 Q2 -- $1.1M -$0.42 -- --
05/09/2023 Q1 -- $2M -$0.42 -- --
03/10/2023 Q4 -- $2.8M -$0.39 -- --
11/10/2022 Q3 -- $1.8M -$0.40 -- --
08/09/2022 Q2 -- $2.4M -$0.41 -- --
05/10/2022 Q1 -- $1.6M -$0.32 -- --
03/18/2022 Q4 -- $1.6M -$0.33 -- --
11/09/2021 Q3 -- $1.2M -$0.26 -- --
08/10/2021 Q2 -- $482K -$0.15 -- --
03/31/2021 Q1 -- $380K -$0.05 -- --
12/31/2020 Q4 -- -- -$0.04 -- --
09/30/2020 Q3 -- -- -$0.03 -- --
06/30/2020 Q2 -- -- -$0.06 -- --
03/31/2020 Q1 -- -- -$0.03 -- --

Janux Therapeutics, Inc. Earnings Questions

  • How Much did Janux Therapeutics, Inc. Generate in Revenue Last Quarter?

    Janux Therapeutics, Inc. reported $10M worth of top line sales in its most recent quarter.

  • Did Janux Therapeutics, Inc. Beat Earnings Last Quarter?

    Janux Therapeutics, Inc. announced earnings per share of -$0.39 which represents a beat of analyst forecast a -$0.61 per share.

  • Is Janux Therapeutics, Inc. Profitable?

    Janux Therapeutics, Inc. reported $9.5M that represents $0.15 per share over the last quarter.

  • What is the Analyst Consensus for Janux Therapeutics, Inc. EPS Next Year?

    Janux Therapeutics, Inc.'s earnings are forecast to decrease from -$1.28 per share to -$1.97 per share next year representing a decrease of -131.65%.

  • When is Janux Therapeutics, Inc.'s Earnings Date?

    Janux Therapeutics, Inc.'s next earnings date is February 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
77
RNG alert for Feb 21

RingCentral, Inc. [RNG] is up 34.37% over the past day.

Sell
9
FROG alert for Feb 21

JFrog Ltd. [FROG] is down 24.98% over the past day.

Buy
72
SNSE alert for Feb 21

Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock